Michael J. Kukla

3.1k total citations · 1 hit paper
44 papers, 2.2k citations indexed

About

Michael J. Kukla is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Michael J. Kukla has authored 44 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Organic Chemistry, 19 papers in Infectious Diseases and 15 papers in Molecular Biology. Recurrent topics in Michael J. Kukla's work include HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (13 papers) and Synthesis and pharmacology of benzodiazepine derivatives (6 papers). Michael J. Kukla is often cited by papers focused on HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (13 papers) and Synthesis and pharmacology of benzodiazepine derivatives (6 papers). Michael J. Kukla collaborates with scholars based in United States, Belgium and Germany. Michael J. Kukla's co-authors include Rudi Pauwels, Koen Andries, Henry J. Breslin, Erik De Clercq, Paul A. J. Janssen, Jan Desmyter, M. Janssen, Donald Ludovici, Robert Woestenborghs and Dominique Schols and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Michael J. Kukla

44 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

1990 673 citations Rudi Pauwels, Koen Andries et al. Nature profile →

Peers

Michael J. Kukla

VIROL

EPIDE

Jill C. Heimbach United States

William E. Kohlbrenner United States

Lori J. Gabryelski United States

Karl D. Hargrave United States

Sudthida Vasavanonda United States

Masaru Ubasawa Japan

Norman E. Wideburg United States

Henry J. Breslin United States

Yasuhiro Koh United States

Kouichi Sekiya Japan

Jill C. Heimbach United States

Michael J. Kukla

1.6k ×1.1

1.5k ×1.3

VIROL

423 ×0.5

958 ×1.4

203 ×0.6

EPIDE

Citations per year, relative to Michael J. Kukla Michael J. Kukla (= 1×) peers Jill C. Heimbach

Countries citing papers authored by Michael J. Kukla

Since Specialization

Citations

This map shows the geographic impact of Michael J. Kukla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Kukla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Kukla more than expected).

Fields of papers citing papers by Michael J. Kukla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Kukla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Kukla. The network helps show where Michael J. Kukla may publish in the future.

Co-authorship network of co-authors of Michael J. Kukla

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Kukla. A scholar is included among the top collaborators of Michael J. Kukla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Kukla. Michael J. Kukla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saha, Ashis, Li Liu, Christophe Meyer, et al.. (2005). Novel triazole based inhibitors of Ras farnesyl transferase. Bioorganic & Medicinal Chemistry Letters. 15(24). 5407–5411. 22 indexed citations

Breslin, Henry J., et al.. (2003). Tripeptidyl-peptidase II (TPP II) inhibitory activity of ( S )-2,3-dihydro-2-(1 H -imidazol-2-yl)-1 H -indoles, a systematic SAR evaluation. Part 2. Bioorganic & Medicinal Chemistry Letters. 13(24). 4467–4471. 15 indexed citations

Ludovici, Donald, Robert W. Kavash, Michael J. Kukla, et al.. (2001). Evolution of Anti-HIV Drug CandidatesPart 2: Diaryltriazine (DATA) Analogues. Bioorganic & Medicinal Chemistry Letters. 11(17). 2229–2234. 98 indexed citations

Ludovici, Donald, Michael J. Kukla, Suma Krishnan, et al.. (2001). Evolution of anti-HIV drug candidates. Part 1: From α-Anilinophenylacetamide (α-APA) to imidoyl thiourea (ITU). Bioorganic & Medicinal Chemistry Letters. 11(17). 2225–2228. 62 indexed citations

Ludovici, Donald, Michael J. Kukla, Hong Ye, et al.. (2001). Evolution of anti-HIV drug candidates. Part 3: diarylpyrimidine (DAPY) analogues. Bioorganic & Medicinal Chemistry Letters. 11(17). 2235–2239. 154 indexed citations

Saha, Ashis, et al.. (2000). Novel antifungals based on 4-substituted imidazole: A combinatorial chemistry approach to lead discovery and optimization. Bioorganic & Medicinal Chemistry Letters. 10(19). 2175–2178. 28 indexed citations

Breslin, Henry J., Michael J. Kukla, Rudi Pauwels, et al.. (1999). Synthesis and anti-HIV activity of 1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-one (TBO) derivatives. truncated 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-ones (TIBO) analogues. Bioorganic & Medicinal Chemistry. 7(11). 2427–2436. 20 indexed citations

Ho, Winston G., Michael J. Kukla, Henry J. Breslin, et al.. (1995). Synthesis and Anti-HIV-1 Activity of 4,5,6,7-Tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TlBO) Derivatives. 4. Journal of Medicinal Chemistry. 38(5). 794–802. 52 indexed citations

Scott, Malcolm K., Ellen W. Baxter, Robert E. Boyd, et al.. (1995). Piperazinylalkyl Heterocycles as Potential Antipsychotic Agents. Journal of Medicinal Chemistry. 38(21). 4198–4210. 18 indexed citations

10.

Breslin, Henry J., Michael J. Kukla, Donald Ludovici, et al.. (1995). Synthesis and Anti-HIV-1 Activity of 4,5,6,7-Tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) Derivatives. 3. Journal of Medicinal Chemistry. 38(5). 771–793. 85 indexed citations

11.

Breslin, Henry J., et al.. (1993). A novel series of N-(1-aminoalkylidene)carboximidamides as potential hypoglycemia agents. Journal of Medicinal Chemistry. 36(11). 1597–1603. 11 indexed citations

12.

Caldwell, Gary W., et al.. (1993). Conformational Analysis of (S)-4,5,6,7-Tetrahydro-5-Methylimidazo [4,5,1-jk][1,4]-Benzodiazepin-2(1H)-one (R78362). Spectroscopy Letters. 26(6). 1005–1022. 1 indexed citations

13.

Scott, Malcolm K., et al.. (1992). Pyrrole Mannich bases as potential antipsychotic agents. Journal of Medicinal Chemistry. 35(3). 552–558. 34 indexed citations

14.

Kukla, Michael J., et al.. (1991). Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. Journal of Medicinal Chemistry. 34(2). 746–751. 79 indexed citations

15.

Kukla, Michael J., Henry J. Breslin, Craig J. Diamond, et al.. (1991). Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. 2. Journal of Medicinal Chemistry. 34(11). 3187–3197. 146 indexed citations

16.

Pauwels, Rudi, Koen Andries, Jan Desmyter, et al.. (1990). Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature. 343(6257). 470–474. 673 indexed citations breakdown →

17.

Kukla, Michael J., Henry J. Breslin, & Alan Gill. (1990). Antihypertensive dihydropyridines with 1,4,4-trisubstitution. Journal of Medicinal Chemistry. 33(1). 223–228. 6 indexed citations

18.

Kukla, Michael J., Henry J. Breslin, & Charles R. Bowden. (1985). Synthesis, characterization, and anorectic testing of the four stereoisomers of cyclo(histidylproline). Journal of Medicinal Chemistry. 28(11). 1745–1747. 19 indexed citations

19.

Kukla, Michael J.. (1977). Synthesis of 1‐amino‐5‐phenyl‐4,5‐dihydro‐3H‐2‐benzazepines and the isomeric 2‐amino‐1‐benzazepines. Journal of Heterocyclic Chemistry. 14(5). 933–935. 6 indexed citations

20.

Bischof, Peter, et al.. (1975). Zur Frage der Homokonjugation in Triquinacen und 2a,4a,8a,8b‐Tetrahydrocyclopent [cd]azulen. Photoelektronenspektroskopische Untersuchungen. Chemische Berichte. 108(4). 1218–1223. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact